All Allergan news

2 hours ago 3 Great Stocks to Buy in a Market Pullback - FOX Business
2 hours ago 3 Great Stocks to Buy in a Market Pullback - FOX Business
Yesterday Drugmakers counter Trump’s ‘murder’ charge - TribLIVE
2 days ago Investors Shift to Healthcare, Retailers as Trump Rally Stalls - Newsmax
2 days ago After Trump rally, equity investors move into healthcare, retailers - Reuters
2 days ago Here are 3 future blue-chips to supercharge your portfolio - Motley Fool
3 days ago Aptar Pharma's Preservative-Free Multidose Dispenser Chosen for the First Time for a Prescription Dry Eye Product in the US with RESTASIS MULTIDOSE™ - Business Wire
5 days ago With Ackman Out, Valeant Confronts Rocky Road to Revival - Newsmax
5 days ago FDA Oks Allergan Dermal Filler - Orange County Business Journal
5 days ago Justices to consider venue for patent litigation - SCOTUSblog
6 days ago Analyzing the Generic Drugs Sector of the US Pharmaceutical Industry 2017 - Business Wire
6 days ago Hedge fund titan’s surefire bet turns into a $4 billion loss - CNBC
8 days ago Biotech set to regain favour after recent thrills and spills - The Courier
9 days ago Here's how much Valeant short sellers have been killing it ever since Bill Ackman got in the stock (VRX) - Stamford Advocate
9 days ago Here's how much Valeant short sellers have been killing it ever since Bill Ackman got in the stock (VRX) - Connecticut Post
9 days ago Here's how much Valeant short sellers have been killing it ever since Bill Ackman got in the stock - Business Insider Australia
10 days ago Court allows Allergan shareholders to go after Ackman, Valeant as a class - Bizjournals
10 days ago Lupin launches pregnancy prevention tablets in the US - dna
10 days ago Bill Ackman can’t escape Valeant lawsuit - New York Post
10 days ago Cramer on how investors should maneuver amid CEO buybacks - CNBC
10 days ago Allergan Just Got Access to Groundbreaking Gene-Editing Treatments for Eye Diseases - Fortune
11 days ago Common explains why he's fighting against a blindness epidemic most people don't know about - Stamford Advocate
11 days ago Common explains why he's fighting against a blindness epidemic most people don't know about - Connecticut Post
11 days ago Bracing for an Eversource rate hike, the attraction of Editas, and more - Boston Globe
11 days ago Common explains why he's fighting against a blindness epidemic most people don't know about - Business Insider Australia
11 days ago Bill Ackman sells Valeant stake after $2.8-billion loss - Business Standard India
11 days ago Common joins Allergan's campaign against vision loss - PRWeek US
11 days ago Case of Eike vs. Allergan (pdf) - Chicago Tribune
11 days ago Cat-loving judge makes case that has nothing to do with cats all about cats - Chicago Tribune
12 days ago What you need to know on Wall Street right now - Business Insider Australia
12 days ago From stock darling to TSX doldrums: Valeant shares down another 10% to all time low - CBC.ca
12 days ago Valeant shares slumps after longtime backer Ackman exits with a loss - The Globe and Mail
12 days ago Editas strikes $90m deal to license eye disease drugs to Ireland’s Allergan - Boston Globe
12 days ago Rapper Common describes almost losing his eyesight when he was 13 - Daily Mail
12 days ago Pfizer Launches Zavicefta™ (ceftazidime-avibactam) in the U.K. and Germany, a New Antibiotic to Treat Complicated Infections Caused by Gram-Negative Bacteria - Business Wire
12 days ago Bill Ackman pinpointed the moment he should've sold out of Valeant — and he's wrong - Stamford Advocate
12 days ago Bill Ackman pinpointed the moment he should've sold out of Valeant — and he's wrong - Connecticut Post
12 days ago Bill Ackman pinpointed the moment he should've sold out of Valeant — and he's wrong - Business Insider
12 days ago Bill Ackman pinpointed the moment he should have sold out of Valeant -- and he's wrong - Business Insider Australia
12 days ago Pershing Square sells final stake in Valeant Pharmaceuticals for large tax loss - CTV News
12 days ago Ackman’s Pershing Square exits ailing investment in Valeant, shares plunge - The Globe and Mail
12 days ago Bill Ackman is selling his entire stake in Valeant Pharmaceuticals - Business Insider
13 days ago Khloe Kardashian's pubic grooming routine has come under fire - Daily Mirror
13 days ago Why Broken-Off Mergers Can Be Big Wins for Investors - Fortune
13 days ago Sosei Subsidiary Heptares and Daiichi Sankyo to Discover and Develop Novel, Small-Molecules for the Treatment of Pain - Business Wire
16 days ago Events Calendar: 8 fun things to do in Morris - Daily Record
16 days ago Don't listen to Khloe Kardashian's advice on vaginas - metro
18 days ago David Tepper is long the market up to his eyeballs - Business Insider Australia
18 days ago Trump sends pharma stocks down with new tweet on drug prices - Boston Globe
18 days ago Pharma giants’ stock prices hit by another Trump tweet - New York Post

Create a custom search

News search supports Google type search formatting and the use of complex boolean. Wrap terms in double quotes for exact phrase matching. Click + to add multiple news search terms to this topic.